In February, the UiO Growth House announced a call for seed funding to support researchers who want to develop their innovative ideas.
The Growth House received 8 applications for seed I where the maximum amount is NOK 50,000 and 22 for seed II where the maximum amount is NOK 200,000. Of these, 8 and 7 projects have been granted seed funding and receive a total of NOK 1.7 million.
The projects that have received seed funding II, will develop methods to monitor patients or premature children and more efficient use of antibiotics as well as develop better organoid technology, self-tests and treatments for infectious diseases.
– It is particularly pleasing that compared to last year, we have more researchers applying for seed funding II. This indicates that we have more researchers with more mature ideas, says innovation director Hilde Nebb in the UiO Growth House.
This was the fourth round of call for seed funding from the Growth House. All the applicants will now be offered follow-up from the UiO Growth House.
The applications have been assessed by innovation advisers in the UiO Growth House together with representatives from the incubators Aleap, ShareLab and Startuplab in Oslo Science Park.
Projects that have been granted funding
With one exception, the researchers come from the Faculty of Mathematics and Natural Sciences (MN) and the Faculty of Medicine (MED).
Project title, project leader, faculty, department – alphabetical order based on the first name of the project leader:
Seed funding II up to NOK 200 000
- 3-IMP: a novel metabolite that predict disease severity in infectious and inflammatory -driven pathogenesis, including adverse cardiovascular outcome
Bente Halvorsen, MED, Institute of Clinical Medicine - A device for the highly sensitive and interference-free analysis of pancreatic hormones
Helena Hru?ková, MN, Department of Chemistry - SmASh-SEP2: Smart Affinity Samplers with cell separation for quantitative protein determination - 2
Leon Reubsaet, MN, Department of Pharmacy - ADD-IT: Accelerated Drug Discovery for Innovative Therapeutics
Siva Krishna Vagolu, MED, Institute of Clinical Medicine - Innovative therapy for MDR/XDR-TB
Tone T?njum, MED, Institute of Clinical Medicine - Pro-resolving agonists against bacterial infections
Trond Vidar Hansen, MN, Department of Pharmacy - Bedside PREvention of critical illness in Preterm infants using ARtificial intelligence and eNose Devices (BePREPAReD)
?sbj?rn Schumacher Westvik, MED, Institute of Clinical Medicine
Seed funding I up to NOK 50 000
- Beyond Word
Claire Prendergast, Faculty of Humanities, Department of Philosophy, Classics, History of Art and Ideas - Dried Fecal Spot – a non-invasive proteomics approach to monitor gut disease state in celiac disease
Jorunn Stamn?s, MED, Institute of Clinical Medicine - Artificial-Intelligence for Characterizing Quantum Photonics Experimental Setup (AI-QPES)
Kishore Thapliyal, MN, Department of Physics - Co-design of a seamless person-centered intervention to optimize medication use across healthcare levels (CIRCLE)
Liv Mathiesen, MN, Department of Pharmacy - Advancing Epidemiological Methods in Primary Care Research on Antibiotics through International Collaboration
Marius Andre Skow, MED, Institute of Health and Society - Computational Lead Optimization of CDK12/13 Inhibitors
Osman Gani, MN, Department of Pharmacy - Design, development and assessment of hydroxide-ion conducting metal-organic frameworks
Petra ?gota Szilágyi, MN, Department of Chemistry - PAGE-BIO
Steven Ray Haakon Wilson, MN, Department of Chemistry